Stuart A. Nicklin

8.4k citations

107 papers · 6.9k · 2 hit papers · h-index 44

Impact in

Genetics top 0.5%
- Virus-based gene therapy research
- Genetic Associations and Epidemiology
Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research

Papers in

Genetics 65
- Virus-based gene therapy research 63
Cardiology and Cardiovascular Medicine 25
- Renin-Angiotensin System Studies 15
- Cardiac Fibrosis and Remodeling 8
- Blood Pressure and Hypertension Studies 3

Co-authors: Andrew Howard Baker (67 shared papers)Alan L. Parker (18 shared papers)Laura Denby (16 shared papers)John H. McVey (14 shared papers)Graeme Milligan (12 shared papers)Lorraine M. Work (19 shared papers)Simon N. Waddington (10 shared papers)Michael J. Hallek (7 shared papers)
Journals: Molecular Therapy (14 papers)Cardiovascular Research (6 papers)Human Gene Therapy (5 papers)Gene Therapy (5 papers)Hypertension (4 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Stuart A. Nicklin

104 papers receiving 6.7k citations

Stuart A. Nicklin's Hit Papers

align trajectories log scale

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options 2020 · 1.1k citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2020 Cardiovascular Research
2008 Cell

Peers

Countries citing papers authored by Stuart A. Nicklin

Since Specialization

Citations

This map shows the geographic impact of Stuart A. Nicklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart A. Nicklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart A. Nicklin more than expected).

Fields of papers citing papers by Stuart A. Nicklin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart A. Nicklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart A. Nicklin. The network helps show where Stuart A. Nicklin may publish in the future.

Co-authors

The 25 scholars most cited alongside Stuart A. Nicklin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stuart A. Nicklin Line = papers co-authored together Stuart A. Nicklin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options Cardiovascular Research ·SAIDI A. MOHIDDIN, Anthony David Dimarco, Vimal H. Patel, Kostas Savvatis, Federica M. Marelli‐Berg, Meena S. Madhur, Maciej Tomaszewski, Pasquale Maffia Hit paper breakdown →	2020	1091
2	Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer Cell ·Simon N. Waddington, John H. McVey, David Bhella, Alan L. Parker, Kristeen Barker, Hideko Atoda, Rebecca Pink, Suzanne M. K. Buckley Hit paper breakdown →	2008	540
3	Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension PLoS Genetics ·Sandosh Padmanabhan, Olle Melander, Toby Johnson, Anna Maria Di Blasio, Davide Gentilini, Claire E. Hastie, Cristina Menni, Maria Cristina Monti	2010	353
4	Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes Blood ·Alan L. Parker, Simon N. Waddington, Campbell G. Nicol, Dmitry M. Shayakhmetov, Suzanne M. K. Buckley, Laura Denby, Geoffrey Kemball‐Cook, Shaoheng Ni	2006	242
5	Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo Nature Biotechnology ·Paul N. Reynolds, Stuart A. Nicklin, Lioudmila Kaliberova, Brian G. Boatman, William E. Grizzle, Irina V. Balyasnikova, Andrew Howard Baker, Sergei M. Danilov	2001	182
6	Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial Cells Molecular Therapy ·Stuart A. Nicklin, Hildegard Buening, Kate L. Dishart, Mahesh de Alwis, Anne Girod, U. Hacker, Adrian James Thrasher, Robin R. Ali	2001	181
7	Targeted Gene Delivery to Vascular Tissue In Vivo by Tropism-Modified Adeno-Associated Virus Vectors Circulation ·Stephen J. White, Stuart A. Nicklin, Hildegard Büning, M. Julia Brosnan, Kristen Leike, Michael J. Hallek, Andrew Howard Baker +1 other	2004	169
8	Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer Blood ·Raúl Alba, Angela C. Bradshaw, Alan L. Parker, David Bhella, Simon N. Waddington, Stuart A. Nicklin, Nico van Rooijen, Jerome H. H. V. Custers	2009	156
9	The influence of adenovirus fiber structure and function on vector development for gene therapy Molecular Therapy ·Stuart A. Nicklin, Eugene Y. Wu, Glen R. Nemerow, Andrew Howard Baker	2005	145
10	Promoters and Control Elements: Designing Expression Cassettes for Gene Therapy Current Gene Therapy ·E D Papadakis, Stuart A. Nicklin, Andrew Howard Baker, Stephen J. White	2004	138
11	Selective Targeting of Gene Transfer to Vascular Endothelial Cells by Use of Peptides Isolated by Phage Display Circulation ·Stuart A. Nicklin, Sarah J. Watkins, Robert E. Hawkins, Andrew Howard Baker +1 other	2000	128
12	Angiotensin-(1–7) and angiotensin-(1–9): function in cardiac and vascular remodelling Clinical Science ·Clare A McKinney, Caroline Fattah, Christopher M. Loughrey, Graeme Milligan, Stuart A. Nicklin	2014	126
13	Ablating Adenovirus Type 5 Fiber–CAR Binding and HI Loop Insertion of the SIGYPLP Peptide Generate an Endothelial Cell-Selective Adenovirus Molecular Therapy ·Stuart A. Nicklin, Dan J. Von Seggern, Lorraine M. Work, Don C.K. Pek, Anna F. Dominiczak, Glen R. Nemerow, Andrew Howard Baker	2001	117
14	Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses Molecular Therapy ·Lorraine M. Work, Hildegard Büning, Ela Hunt, Stuart A. Nicklin, Laura Denby, Nicola Britton, Kristen Leike, Margarete Odenthal	2006	112
15	Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2 Circulation Research ·Anna Zoccarato, Nicoletta Concetta Surdo, Jan Magnus Aronsen, Laura Ashley Fields, Luisa Mancuso, Giuliano Dodoni, Alessandra Stangherlin, Craig Livie	2015	108
16	Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors Viruses ·Lynda Coughlan, Raúl Alba, Alan L. Parker, Angela C. Bradshaw, Iain A. McNeish, Stuart A. Nicklin, Andrew Howard Baker	2010	101
17	Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats Molecular Therapy ·Campbell G. Nicol, Delyth Graham, Stephen J. White, Theodore A Smith, Stuart A. Nicklin, Susan C. Stevenson, Andrew Howard Baker +1 other	2004	98
18	Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors Blood ·Raúl Alba, Angela C. Bradshaw, Lynda Coughlan, Laura Denby, Robert A. McDonald, Simon N. Waddington, Suzanne M. K. Buckley, Jenny A. Greig	2010	98
19	Development of Efficient Viral Vectors Selective for Vascular Smooth Muscle Cells Molecular Therapy ·Lorraine M. Work, Stuart A. Nicklin, Nick J.R. Brain, Kate L. Dishart, Dan J. Von Seggern, Michael J. Hallek, Hildegard Büning, Andrew Howard Baker	2003	96
20	Angiotensin-(1-9) Attenuates Cardiac Fibrosis in the Stroke-Prone Spontaneously Hypertensive Rat via the Angiotensin Type 2 Receptor Hypertension ·Mónica Flores‐Muñoz, Lorraine M. Work, K. Bishop Douglas, Laura Denby, Anna F. Dominiczak, Delyth Graham, Stuart A. Nicklin	2011	93

About Stuart A. Nicklin

Stuart A. Nicklin is a scholar working on Genetics, Cardiology and Cardiovascular Medicine, Molecular Biology, Hematology and Surgery, having authored 107 papers that have together received 6.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (63 papers), Renin-Angiotensin System Studies (15 papers), Cardiac Fibrosis and Remodeling (8 papers), Receptor Mechanisms and Signaling (6 papers), RNA Interference and Gene Delivery (5 papers), Blood Pressure and Hypertension Studies (3 papers), Iron Metabolism and Disorders (2 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Genetics (3.2k citations), Infectious Diseases (789 citations), Cardiology and Cardiovascular Medicine (1k citations), Biological Psychiatry (36 citations) and Molecular Biology (1.2k citations). Stuart A. Nicklin has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Andrew Howard Baker, Alan L. Parker, Laura Denby, John H. McVey, Graeme Milligan, Lorraine M. Work, Simon N. Waddington, Michael J. Hallek, Suzanne M. K. Buckley and Stephen J. White. Their work appears in journals such as Molecular Therapy, Cardiovascular Research, Human Gene Therapy, Gene Therapy and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Stuart A. Nicklin

Impact in

Papers in i

In The Last Decade

Stuart A. Nicklin

Stuart A. Nicklin's Hit Papers

Peers

Countries citing papers authored by Stuart A. Nicklin

Fields of papers citing papers by Stuart A. Nicklin

All Works

About Stuart A. Nicklin

Explore authors with similar magnitude of impact

Papers in